LatAmGrowth SPAC
NASDAQ:LATG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aarey Drugs and Pharmaceuticals Ltd
NSE:AAREYDRUGS
|
IN |
LatAmGrowth SPAC
Revenue
LatAmGrowth SPAC
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
LatAmGrowth SPAC
NASDAQ:LATG
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Revenue
$1.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Revenue
$7.5B
|
CAGR 3-Years
89%
|
CAGR 5-Years
7%
|
CAGR 10-Years
25%
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Revenue
$3.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Revenue
$3.6B
|
CAGR 3-Years
32%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
LatAmGrowth SPAC
Glance View
LatAmGrowth SPAC is a blank check company. The company is headquartered in Los Angeles, California. The company went IPO on 2022-01-25. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination. The firm intends to search its focus on technology sector in countries, including United States and Brazil. The firm has not commenced any operations nor generated any revenue.
See Also
What is LatAmGrowth SPAC's Revenue?
Revenue
0
USD
Based on the financial report for Dec 31, 2023, LatAmGrowth SPAC's Revenue amounts to 0 USD.
